lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunosupressandid - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
cantar tablett
teva pharma b.v. - kandesartaan - tablett - 8mg 56tk; 8mg 14tk; 8mg 250tk; 8mg 30tk; 8mg 60tk; 8mg 90tk; 8mg 20tk; 8mg 28tk; 8mg 7tk; 8mg 100tk
cantar tablett
teva pharma b.v. - kandesartaan - tablett - 4mg 60tk; 4mg 300tk; 4mg 98tk; 4mg 14tk; 4mg 7tk; 4mg 50tk; 4mg 20tk; 4mg 100tk; 4mg 28tk
jardiance
boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - diabeetis kasutatavad ravimid - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ja 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.
candegamma tablett
woerwag pharma gmbh & co. kg - kandesartaan - tablett - 4mg 28tk; 4mg 30tk; 4mg 98tk; 4mg 100tk; 4mg 56tk; 4mg 10tk; 4mg 14tk